Catalent handed two Form 483s, including for Sarepta gene therapy site
Catalent handed two Form 483s, including for Sarepta gene therapy site
Catalent handed two Form 483s, including for Sarepta gene therapy site
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.